Skip to main content
. 2013 Mar 3;6(4):238–243.

Table 2.

Cycle characteristics and outcomes of patients in the treatment groups


hMG (n=38) rFSH (n=42) P value

Duration of gonadotropin stimulation (Days) 11.46 ± 1.90a 10.36 ± 1.58 0.025*
Total dose of gonadotropin (IU) 1716.06 ± 511.52 1429.50 ± 340.54 0.57
Peak E2 (pg/mL) 2880.23 ± 1284.22 3779.52 ± 1487.70 0.02*
Number of mature follicles (≥14 mm) 5.92 ± 2.72 6.24 ± 3.85 0.75
Number of intermediate sized follicles (10-14 mm) 9.35 ± 3.61 12.69 ± 3.98 0.001*
Endometrial thickness (mm) 10.54 ± 2.03 11.45 ± 1.85 0.06
Number of oocytes retrieved 9.54 ± 4.31 13.60 ± 5.56 0.002*
Number of MII oocytes 7.65 ± 3.39 11.20 ± 5.06 0.003*
Percentage of MII oocytes 81.24 (40-100)b 82.13 (37.5-100) 0.80
Number of oocytes fertilized 4.46 ± 2.62 6.07 ± 3.55 0.70
Fertilization rate (%) 56.95 55.53 0.77
Number of top quality embryos 1.29 (0- 3) 1.48 (0-3) 0.48
Number of embryos transferred 3 (1-4) 3 (1-4) 0.25
Clinical pregnancy rate per cycle (%) 23.1 40.5 0.14
Coasting requirement (%) 19.2 48.9 0.013*
OHSS (n,%) 0 (0.0%) 5 (11.9%)c 0.14
Take home baby rate per cycle (%) 23.1 35.7 0.27

a; Mean ± SD , b; Median (range), c; Number (percentage) and *; p< 0.05 is considered significant.